Vertex Pharmaceuticals, Inc. (VRTX)
457.36
-5.77
(-1.25%)
USD |
NASDAQ |
Dec 04, 16:00
458.85
+1.49
(+0.33%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 116.04B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.12B |
| Amgen, Inc. | 183.17B |
| IDEXX Laboratories, Inc. | 57.29B |
| Eli Lilly & Co. | 907.99B |
| Alnylam Pharmaceuticals, Inc. | 61.48B |
Market Cap Related Metrics
| PE Ratio | 32.23 |
| PS Ratio | 10.10 |
| Price to Book Value | 6.700 |
| Price to Free Cash Flow | 35.51 |
| Price | 457.36 |
| Earnings Yield | 3.10% |
| Operating PE Ratio | 26.17 |
| Normalized PE Ratio | 29.23 |